Total Payments
$24,872
2024 Payments
$4,194
Companies
44
Transactions
1,922
Medicare Patients
5,674
Medicare Billing
$669,188
Payment Breakdown by Category
Food & Beverage$21,886 (88.0%)
Consulting$2,943 (11.8%)
Education$22.80 (0.1%)
Other$20.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,886 | 1,915 | 88.0% |
| Consulting Fee | $2,943 | 2 | 11.8% |
| Education | $22.80 | 4 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $5,699 | 237 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $4,279 | 340 | $0 (2024) |
| ABBVIE INC. | $2,925 | 231 | $0 (2024) |
| Gilead Sciences, Inc. | $1,421 | 149 | $0 (2024) |
| GENZYME CORPORATION | $945.81 | 54 | $0 (2024) |
| Celgene Corporation | $815.68 | 76 | $0 (2024) |
| Allergan Inc. | $772.18 | 142 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $735.04 | 56 | $0 (2024) |
| PFIZER INC. | $696.89 | 54 | $0 (2024) |
| Daiichi Sankyo Inc. | $619.35 | 45 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,194 | 342 | Janssen Biotech, Inc. ($960.41) |
| 2023 | $7,190 | 353 | Janssen Biotech, Inc. ($3,590) |
| 2022 | $3,408 | 272 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($662.73) |
| 2021 | $2,481 | 218 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($535.35) |
| 2020 | $1,477 | 115 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($712.04) |
| 2019 | $2,341 | 250 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($1,006) |
| 2018 | $1,828 | 205 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($535.05) |
| 2017 | $1,953 | 167 | Valeant Pharmaceuticals North America LLC ($364.01) |
All Payment Transactions
1,922 individual payment records from CMS Open Payments — Page 1 of 77
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Gastroenterology | ||||||
| 12/24/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: LIVER DISEASE | ||||||
| 12/19/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: LIVER DISEASE | ||||||
| 12/19/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/19/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $3.97 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: LIVER DISEASE | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/16/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: LIVER DISEASE | ||||||
| 12/15/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.52 | General |
| 12/12/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Immunology | ||||||
| 12/12/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $3.36 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/12/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $2.98 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: LIVER DISEASE | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $3.52 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $3.36 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.79 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,466 | 1,627 | $1.3M | $173,844 |
| 2022 | 20 | 1,506 | 1,677 | $1.3M | $174,886 |
| 2021 | 20 | 1,493 | 1,751 | $1.2M | $191,771 |
| 2020 | 15 | 1,209 | 1,425 | $890,350 | $128,687 |
Total Patients
5,674
Total Services
6,480
Medicare Billing
$669,188
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 217 | 284 | $99,116 | $29,597 | 29.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 136 | 137 | $259,958 | $29,050 | 11.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 179 | 185 | $81,030 | $20,420 | 25.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 173 | 180 | $287,100 | $16,781 | 5.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 110 | 110 | $48,400 | $14,808 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 160 | 206 | $48,410 | $14,128 | 29.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 119 | 144 | $33,120 | $9,717 | 29.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 88 | 90 | $163,350 | $8,248 | 5.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 83 | 83 | $29,216 | $5,709 | 19.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 28 | 29 | $49,126 | $5,490 | 11.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 35 | 36 | $60,984 | $4,823 | 7.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 22 | $13,895 | $3,106 | 22.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 15 | 15 | $25,410 | $2,848 | 11.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 28 | $9,296 | $2,842 | 30.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $25,410 | $2,193 | 8.6% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 13 | 13 | $21,093 | $1,568 | 7.4% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 16 | 16 | $5,815 | $1,506 | 25.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 16 | $2,288 | $594.60 | 26.0% |
| 43450 | Dilation of esophagus | Facility | 2023 | 12 | 12 | $15,000 | $414.11 | 2.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 216 | 285 | $99,465 | $26,950 | 27.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 123 | 123 | $233,393 | $26,812 | 11.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 181 | 195 | $311,025 | $19,046 | 6.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 187 | 242 | $56,870 | $18,917 | 33.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 147 | 152 | $66,576 | $17,261 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 99 | 99 | $43,560 | $11,080 | 25.4% |
About Dr. Mark Cerefice, M.D
Dr. Mark Cerefice, M.D is a Gastroenterology healthcare provider based in Brick, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1417165416.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Cerefice, M.D has received a total of $24,872 in payments from pharmaceutical and medical device companies, with $4,194 received in 2024. These payments were reported across 1,922 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($21,886).
As a Medicare-enrolled provider, Cerefice has provided services to 5,674 Medicare beneficiaries, totaling 6,480 services with total Medicare billing of $669,188. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Brick, NJ
- Active Since 05/21/2007
- Last Updated 06/13/2013
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1417165416
Products in Payments
- STELARA (Biological) $4,821
- XIFAXAN (Drug) $3,102
- DUPIXENT (Biological) $1,016
- LINZESS (Drug) $860.71
- ZEPOSIA (Drug) $793.96
- TRULANCE (Drug) $748.85
- ZENPEP (Drug) $719.03
- TREMFYA (Drug) $686.86
- XELJANZ (Drug) $670.32
- INJECTAFER (Drug) $587.73
- SKYRIZI (Biological) $567.84
- Talicia (Drug) $516.99
- RINVOQ (Biological) $512.24
- HUMIRA (Biological) $461.34
- VIBERZI (Drug) $449.93
- DIFICID (Drug) $399.99
- MOVIPREP (Drug) $375.60
- Linzess (Drug) $363.03
- IBSRELA (Drug) $351.91
- REMICADE (Biological) $349.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Brick
Dr. William Basri, M.d, M.D
Gastroenterology — Payments: $24,969
Gastroenterology $24,969
Mr. Arkady Broder, Md, MD
Gastroenterology — Payments: $20,023
Gastroenterology $20,023
Kenny Chiu, Md, MD
Gastroenterology — Payments: $14,263
Gastroenterology $14,263
Dr. Kenny Hui, M.d, M.D
Gastroenterology — Payments: $14,084
Gastroenterology $14,084
Dr. Matthew Tangorra, D.o, D.O
Gastroenterology — Payments: $14,049
Gastroenterology $14,049
Dr. Neal Winzelberg, Md, MD
Gastroenterology — Payments: $9,650
Gastroenterology $9,650